These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10739779)

  • 1. Effect of biocompatibility of hemodialysis membranes on serum albumin levels.
    Tayeb JS; Provenzano R; El-Ghoroury M; Bellovich K; Khairullah Q; Pieper D; Morrison L; Calleja Y
    Am J Kidney Dis; 2000 Apr; 35(4):606-10. PubMed ID: 10739779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dialyzer membrane on serum albumin levels in patients receiving hemodialysis.
    Rault RM
    Int J Artif Organs; 2003 Nov; 26(11):1002-4. PubMed ID: 14708829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemodialysis membranes on serum albumin.
    Locatelli F;
    Am J Kidney Dis; 2001 Feb; 37(2):455-6. PubMed ID: 11157397
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of hemodialysis with frequent use of cuprophan and polysulfone membranes on activation of complement in patients with chronic renal failure].
    Zukowska-Szczechowska E; Moczulski D; Grzeszczak W; Gosek K; Augustyn M; Staszewicz P
    Pol Arch Med Wewn; 1996 Nov; 96(5):458-68. PubMed ID: 9091856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse.
    DiRaimondo CR; Pollak VE
    Am J Kidney Dis; 1989 May; 13(5):390-5. PubMed ID: 2655439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ofloxacin clearance during hemodialysis: a comparison of polysulfone and cellulose acetate hemodialyzers.
    Thalhammer F; Kletzmayr J; El Menyawi I; Kovarik J; Rosenkranz AR; Traunmüller F; Hörl WH; Burgmann H
    Am J Kidney Dis; 1998 Oct; 32(4):642-5. PubMed ID: 9774127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the membrane biocompatibility on nutritional parameters in chronic hemodialysis patients.
    Parker TF; Wingard RL; Husni L; Ikizler TA; Parker RA; Hakim RM
    Kidney Int; 1996 Feb; 49(2):551-6. PubMed ID: 8821843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Choice of Hemodialysis Membrane Affects Bisphenol A Levels in Blood.
    Bosch-Panadero E; Mas S; Sanchez-Ospina D; Camarero V; Pérez-Gómez MV; Saez-Calero I; Abaigar P; Ortiz A; Egido J; González-Parra E
    J Am Soc Nephrol; 2016 May; 27(5):1566-74. PubMed ID: 26432902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers.
    Nensel U; Röckel A; Hillenbrand T; Bartel J
    Blood Purif; 1994; 12(2):128-34. PubMed ID: 7530014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved preservation of residual renal function in chronic hemodialysis patients using polysulfone dialyzers.
    McCarthy JT; Jenson BM; Squillace DP; Williams AW
    Am J Kidney Dis; 1997 Apr; 29(4):576-83. PubMed ID: 9100048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes.
    Memoli B; Minutolo R; Bisesti V; Postiglione L; Conti A; Marzano L; Capuano A; Andreucci M; Balletta MM; Guida B; Tetta C;
    Am J Kidney Dis; 2002 Feb; 39(2):266-73. PubMed ID: 11840366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biocompatibility and permeability of dialyzer membranes do not affect anemia, erythropoietin dosage or mortality in japanese patients on chronic non-reuse hemodialysis: a prospective cohort study from the J-DOPPS II study.
    Yokoyama H; Kawaguchi T; Wada T; Takahashi Y; Higashi T; Yamazaki S; Fukuhara S; Akiba T; Akizawa T; Asano Y; Kurokawa K; Saito A;
    Nephron Clin Pract; 2008; 109(2):c100-8. PubMed ID: 18596379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle molecule clearance does not influence protein intake in hemodialysis patients.
    Marcus RG; Cohl E; Uribarri J
    Am J Kidney Dis; 1998 Mar; 31(3):491-4. PubMed ID: 9506686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of membrane composition on cytokine production and clinical symptoms during hemodialysis: a crossover study.
    Singh NP; Bansal R; Thakur A; Kohli R; Bansal RC; Agarwal SK
    Ren Fail; 2003 May; 25(3):419-30. PubMed ID: 12803505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes.
    Degiannis D; Czarnecki M; Donati D; Homer L; Eisinger RP; Raska K; Raskova J
    Am J Nephrol; 1990; 10(4):276-82. PubMed ID: 2240054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of hemodialysis using cuprophan and polysulfone dialyzers on rosette tests, concentration of immunoglobulins and complement components in serum of patients with chronic renal failure].
    Starzyk J; Bartelik S; Sarnecka S
    Wiad Lek; 1994 Jul; 47(13-14):523-6. PubMed ID: 7716940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive evaluation of acute immunological changes induced by cuprophane and polysulfone membranes in a patient on chronic hemodialysis.
    Patarca R; Perez G; Gonzalez A; Garcia-Morales RO; Gamble R; Klimas N; Fletcher MA
    Am J Nephrol; 1992; 12(4):274-8. PubMed ID: 1481878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V; Kes P; Zeljko R; Kusec V
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.